Market Cap 72.87M
Revenue (ttm) 0.00
Net Income (ttm) -23.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 71,800
Avg Vol 144,168
Day's Range N/A - N/A
Shares Out 59.24M
Stochastic %K 20%
Beta 2.99
Analysts Strong Sell
Price Target $4.00

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management i...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 506 8462
Address:
1350 South Loop Road, Alameda, United States
BC322032
BC322032 Aug. 21 at 1:11 PM
$VANI Just a question of who will make me rich faster, VANI or $AABB as both are ready to explode!
0 · Reply
BC322032
BC322032 Aug. 19 at 4:11 PM
$VANI Diet pills do NOT WORK as well as what VANI has. Folks just quite shots and pills. The VANI solution is the CLEAR WINNER! https://www.cnbc.com/2025/08/19/viking-therapeutics-obesity-pill-data.html
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Aug. 14 at 7:59 PM
$VANI signal 54.5%
0 · Reply
BC322032
BC322032 Aug. 14 at 2:09 PM
$VANI Adding!
0 · Reply
d_risk
d_risk Aug. 14 at 3:37 AM
$VANI - Vivani Medical Inc. Common Stock (DE) - 10Q - Updated Risk Factors VANI’s 10-Q risk update: Minor pharma development risk edits; new warning on tariffs and trade restrictions threatening sourcing, costs, and operations due to shifting US-EU trade policies and investigations. #Pharmaceuticals #US-EUTrade #SupplyChainRisk #Tariffs #TradeRestrictions 🟢 Added 🟠 Removed https://d-risk.ai/VANI/10-Q/2025-08-13
1 · Reply
66Harry
66Harry Aug. 13 at 11:02 PM
$VANI \Once separate makes easer for take over.
0 · Reply
ballyhooo
ballyhooo Aug. 13 at 9:11 PM
$VANI The Cortigent spin off in Q2 or Q3!
1 · Reply
Joesh82
Joesh82 Aug. 13 at 8:34 PM
$VANI Private placement of $10M done on August 11th by two investors, 7,936,507 shares @ $1.26 - so more buying from Gregg Williams - secures Vivani’s financial position into the second half of 2026
0 · Reply
Joesh82
Joesh82 Aug. 13 at 8:22 PM
$VANI https://investors.vivani.com/investors/news-events/press-releases/detail/199/vivani-medical-provides-business-update-including-10m
0 · Reply
BC322032
BC322032 Aug. 13 at 3:38 PM
$VANI There is SUCH a need for VANI's winning drug. Can not get to market fast enough! https://www.fastcompany.com/91385390/wegovy-zepbound-patients-resorting-cost-saving-measures-stay-weight-loss-drugs
0 · Reply
Latest News on VANI
Vivani Medical to Present at TIDES Conference 2024

May 9, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical to Present at TIDES Conference 2024


Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 29, 2024, 7:25 AM EST - 1 year ago

Vivani Medical (VANI) stock price surged: is it a good buy?


Vivani Medical to Present at BIO Investor Forum

Oct 16, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at BIO Investor Forum


Vivani Medical to Present at the Boulder Peptide Symposium

Sep 7, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the Boulder Peptide Symposium


Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

Aug 31, 2022, 6:00 AM EDT - 3 years ago

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)


BC322032
BC322032 Aug. 21 at 1:11 PM
$VANI Just a question of who will make me rich faster, VANI or $AABB as both are ready to explode!
0 · Reply
BC322032
BC322032 Aug. 19 at 4:11 PM
$VANI Diet pills do NOT WORK as well as what VANI has. Folks just quite shots and pills. The VANI solution is the CLEAR WINNER! https://www.cnbc.com/2025/08/19/viking-therapeutics-obesity-pill-data.html
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Aug. 14 at 7:59 PM
$VANI signal 54.5%
0 · Reply
BC322032
BC322032 Aug. 14 at 2:09 PM
$VANI Adding!
0 · Reply
d_risk
d_risk Aug. 14 at 3:37 AM
$VANI - Vivani Medical Inc. Common Stock (DE) - 10Q - Updated Risk Factors VANI’s 10-Q risk update: Minor pharma development risk edits; new warning on tariffs and trade restrictions threatening sourcing, costs, and operations due to shifting US-EU trade policies and investigations. #Pharmaceuticals #US-EUTrade #SupplyChainRisk #Tariffs #TradeRestrictions 🟢 Added 🟠 Removed https://d-risk.ai/VANI/10-Q/2025-08-13
1 · Reply
66Harry
66Harry Aug. 13 at 11:02 PM
$VANI \Once separate makes easer for take over.
0 · Reply
ballyhooo
ballyhooo Aug. 13 at 9:11 PM
$VANI The Cortigent spin off in Q2 or Q3!
1 · Reply
Joesh82
Joesh82 Aug. 13 at 8:34 PM
$VANI Private placement of $10M done on August 11th by two investors, 7,936,507 shares @ $1.26 - so more buying from Gregg Williams - secures Vivani’s financial position into the second half of 2026
0 · Reply
Joesh82
Joesh82 Aug. 13 at 8:22 PM
$VANI https://investors.vivani.com/investors/news-events/press-releases/detail/199/vivani-medical-provides-business-update-including-10m
0 · Reply
BC322032
BC322032 Aug. 13 at 3:38 PM
$VANI There is SUCH a need for VANI's winning drug. Can not get to market fast enough! https://www.fastcompany.com/91385390/wegovy-zepbound-patients-resorting-cost-saving-measures-stay-weight-loss-drugs
0 · Reply
ballyhooo
ballyhooo Aug. 13 at 11:29 AM
$VANI earnings should post any day now!
1 · Reply
BC322032
BC322032 Aug. 13 at 11:07 AM
0 · Reply
signaljumper
signaljumper Aug. 12 at 3:57 PM
$VANI loading forcthe coming apin Off Planned spin-off of Cortigent as independent public company by Q3 2025
1 · Reply
Repunza
Repunza Aug. 11 at 6:52 PM
$VANI The way this is going it's gonna be under $1 again before you know it.
1 · Reply
Stocksprofessional
Stocksprofessional Aug. 8 at 4:54 AM
$VANI I couldn’t agree more. Eli Lilly’s weak obesity pill results highlight the urgent need for more effective and convenient treatments—an opening Vivani is primed to exploit. Its long-acting GLP-1 implant can deliver 6–12 months of continuous therapy from a single procedure, eliminating adherence issues and maintaining steady drug levels that may reduce side effects. If upcoming human trials validate the strong preclinical results, Vivani could secure a significant share of an obesity market projected to exceed $100 billion annually, positioning its technology as a true next-generation solution in the space.
0 · Reply
Stocksprofessional
Stocksprofessional Aug. 8 at 4:48 AM
$VANI Instead of patients needing to remember a daily pill (like Lilly’s orforglipron) or a weekly injection (like Wegovy/Zepbound), Vivani’s implant could deliver 6 months to 1 year of continuous GLP-1 therapy from a single procedure. Potential benefits include: • Better adherence — eliminates missed doses that can reduce treatment effectiveness. • Steadier drug levels — may lower the risk of side effects from peak-and-trough fluctuations. • Lower treatment burden — ideal for those who dislike injections or complex regimens. • Stronger payer appeal — insurers value therapies that ensure consistent, long-term compliance.
0 · Reply
BC322032
BC322032 Aug. 7 at 11:53 PM
$VANI - Diet pill did NOT meet targets. We are winner! Daily minimal pull vs 1x mega loss insert!
2 · Reply
Earl40
Earl40 Aug. 7 at 7:40 PM
$VANI I don't want to be no clock watcher Standin' in line I don't want to be someone in love Wastin' my time Can I get right to the point, baby You know I care Tell me what you want, yeah, baby And I'm right here Now tell me what it is I'm supposed to do And someday I'll get to you But in the meantime I know what I gotta do Hurry up and wait
0 · Reply
66Harry
66Harry Aug. 7 at 2:36 PM
$VANI So what happens now ?
3 · Reply
66Harry
66Harry Aug. 6 at 10:48 PM
$VANI Pretty sad no coverage on Vani on the report.
0 · Reply
Raxothus
Raxothus Aug. 6 at 4:29 PM
EOD FOLLOW-UP – 08/06/25 Tracking continuation watch from 08/05 based on today’s highs vs prior close ✅ $SWIN – Closed 3.99, hit 4.68 (+17.3%). Gapped and pushed to 4.68 watch level before fading. ✅ $ATLX – Closed 6.05, hit 7.00 (+15.7%). Cleared 6.94 watch level early and extended before fading. ❌ $IMMX – Closed 2.87, hit 2.95 (+2.8%). Flat open and faded immediately. ❌ $VANI – Closed 1.49, hit 1.48 (–0.7%). No gap, no push. Failed to trigger. ✅ $NB – Closed 3.85, hit 4.44 (+15.3%). Strong open, cleared 4.23+ level and extended. 📊 Recap Total: 5 Winners: 3 Faders: 2 Accuracy: 60% ⚠️ $SWIN, $ATLX, and $NB delivered solid continuation through key levels. $IMMX and $VANI showed no strength and failed to trigger clean setups.
1 · Reply
bullseye86
bullseye86 Aug. 6 at 2:32 PM
$VANI holding up nicely … this one’s a long hold. Maybe slowly accumulate over time. The potential is insane for the medical field…Flying under the radar as of now until we get more results in (next year)
1 · Reply